Heaton Group
Heaton Group is a family-owned Czech pharmaceutical company that develops, licenses, and distributes prescription medicines, OTC medical devices (GYNELLA brand), cosmetics, and foods for special medical purposes across gynecology, urology, nephrology, oncology, and diabetology, serving healthcare professionals and female consumers in 27+ countries.
- Company typePrivate
- Founded2002
- HeadquartersPrague, Czechia
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Heaton Group does
Heaton Group is a privately-held Czech pharmaceutical company founded in 2002 and headquartered in Prague. It supplies pharmaceuticals and medical devices across five therapeutic areas — gynecology, urology, nephrology, oncology, and diabetology — and also markets cosmetics and foods for special medical purposes. The company is wholly family-owned by the Frič family (no external investors), operates through a Czech holding structure (HEATON k.s.) created in 2012, and is run by the founders' children: Managing Director Jaromír Frič Jr. and Business Development Director Natálie Kazíková.
The portfolio rests on two proprietary technology platforms: a tyndallization process that produces the first vaginal paraprobiotic preserving whole-cell immunogenic structure, and the patented TIAB complex (titanium dioxide microcrystals with bound silver ions) delivering antimicrobial, barrier, and regenerative effects. The OTC women's health franchise is marketed under the GYNELLA sub-brand and spans intimate hygiene, vaginal infections, atrophy, fertility support, and cystitis; Heaton also holds more than 30 marketing authorizations for prescription medicines and distributes foods for special medical purposes. Distribution combines owned field-sales forces in Czech Republic, Germany, Slovakia, and Romania with distribution partners covering 30+ additional countries, anchored by wholly-owned subsidiaries in those four European markets plus a Singapore subsidiary opened in October 2024 as an APAC gateway.
The business model is a hybrid licensing-distribution model: Heaton partners with active-substance manufacturers for product licensing, maintains its own marketing authorizations and ISO/GMP/GDP certifications, and generates revenue through pharmacy-channel OTC sales, prescription-medicine promotion via medical representatives, and direct-to-consumer e-commerce through the GYNELLA storefront. Customer segments split between prescribing healthcare professionals (gynecologists, urologists, oncologists, diabetologists) for Rx products and female end-consumers for the OTC line. Geographic exposure is concentrated in Central and Eastern Europe with growing Western European and nascent APAC reach.
Heaton Group firmographics
Firmographics- Name
- Heaton Group
- Legal name
- HEATON k.s.
- Website
- https://heaton.cz
- Company type
- Private
- Founded year
- 2002
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Heaton Group is a family-owned Czech pharmaceutical company that develops, licenses, and distributes prescription medicines, OTC medical devices (GYNELLA brand), cosmetics, and foods for special medical purposes across gynecology, urology, nephrology, oncology, and diabetology, serving healthcare professionals and female consumers in 27+ countries.
- Ownership category
- akta.pro rank
Heaton Group industry classification
Industry- Product category
- Pharmaceutical Products
- NAICS
- Pharmaceutical Preparation Manufacturing (325412), Surgical Appliance and Supplies Manufacturing (339113)
- SIC
- Pharmaceutical Preparations (2834), Surgical & Medical Instruments & Apparatus (3841), Perfumes, Cosmetics & Other Toilet Preparations (2844)
- akta.pro primary industry
- Women’s Health (OTC Gynecologic) (HLAIADAJ)
- akta.pro secondary industries
- Men’s Health (OTC Urologic & Sexual Health) (HLAIADAK), Fertility & Ovulation Products (OTC) (CRABAIAK), Feminine & Sexual Wellness OTC (Yeast Infection OTC, Lubricants, Condoms, Pregnancy Tests) (CRADAMAH)
Keywords
Where Heaton Group is headquartered
LocationHeadquarters
- HQ city
- Prague
- HQ country
- Czechia
- HQ region
- Europe
Offices5 records
Markets served
Heaton Group business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Personnel, Marketing or Sales, Technology or R&D, Operations, Others
Revenue model
- Prescription Medicines: Heaton holds over 30 marketing authorizations for prescription medicines across therapeutic areas including gynecology, urology, nephrology, oncology, and substitution treatment. Products are promoted through medical representatives.
- Medical Devices (OTC): OTC medical devices sold in pharmacies under the GYNELLA brand including Silver Caps, Silver Foam, Flora, Balance, AtroGel, Natal Ferti Gel, and intimate hygiene products. Available without prescription.
- Cosmetics: Cosmetic products under the GYNELLA brand for intimate hygiene.
- Foods for Special Medical Purposes: Specialized nutritional products for specific medical conditions.
Go-to-market motion2 records
Distribution channels4 records
Marketing channels6 records
Heaton Group product offering
Product offeringCore offering
Heaton Group supplies prescription pharmaceuticals and OTC medical devices across therapeutic areas including gynecology, urology, nephrology, oncology, diabetology, and hospital care. The company holds more than 30 marketing authorizations for prescription medicines and operates the GYNELLA brand of OTC women's health medical devices (Flora, Balance, Silver Caps, Silver Foam, AtroGel, Natal Ferti Gel, Cystilab, intimate hygiene line), along with cosmetics and foods for special medical purposes. Products are sold in 27 countries through owned sales teams, subsidiaries, and a network of international distribution partners.
Product overview
Heaton Group is an international pharmaceutical company headquartered in Prague, Czech Republic, operating as a privately-owned enterprise. The company offers a diversified portfolio consisting of: (1) Prescription Medicines – more than 30 marketing authorizations covering gynecology, urology, nephrology, oncology, substitution treatment, and hospital care segments; (2) Medical Devices – the core GYNELLA® product line for women's health including GYNELLA® Flora, Balance, Silver Caps, Silver Foam, AtroGel, Natal Ferti Gel, Cystilab, Intimate Foam, Intimate Wash, Girl Intimate Wash, plus ATUCARE, VREYA, and ANDRYLL Silver Gel; and (3) Cosmetics within the GYNELLA brand. The GYNELLA® products form the primary OTC medical device portfolio focused on gynecological applications including vaginal infections, vaginal atrophy/dryness, vaginal microbiota support, fertility, and intimate hygiene. The company operates through its own sales teams in Czech Republic, Germany, Slovakia, and Romania, with distribution partnerships extending to 27+ countries including the new Singapore subsidiary.
Differentiator
Problem solved
Functional benefit
Brands
- GYNELLA: OTC brand covering intimate hygiene, vaginal infections, vaginal atrophy, fertility, and vaginal microflora products including GYNELLA Flora, GYNELLA Balance, GYNELLA AtroGel, GYNELLA Natal Ferti Gel, GYNELLA Silver Caps, GYNELLA Silver Foam, GYNELLA Intimate Foam, GYNELLA Intimate Wash, GYNELLA Girl Intimate Wash, and GYNELLA Cystilab.
- Gynella
- Andryll
Products and services
- GYNELLA Flora
Quantifiable outcome
- GYNELLA brand launched successfully in 7 European countries
- +1 more outcomes
Companies that use Heaton Group
Customer profileSegments3 records
Ideal customer profiles2 records
Heaton Group technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature2 records
Heaton Group partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core.
- Active Substance ManufacturerscoreLong-term partnerships with manufacturers of active substances for product licensing. These partnerships enable Heaton to offer a state-of-the-art portfolio with large production capacity across various pharmaceutical forms including tablets, capsules, gels, foams, and injectable solutions.
- Distribution PartnerscoreInternational distribution partners operating in various territories with exclusivity arrangements. Current partners cover countries including Austria, Bulgaria, Croatia, Czech Republic, Denmark, UAE, Germany, Malta, Mongolia, Norway, Moldova, Pakistan, Romania, Slovakia, Slovenia.
Scale indicators5 records
Recent moves12 records
Expansion highlights6 records
Heaton Group competitors and assessment
Company assessmentBroad incumbents
- Perrigo Company: US-headquartered OTC consumer healthcare leader with strong presence in Europe. Direct overlap with Heaton's OTC medical device and women's health positioning through pharmacy distribution.
- Organon & Co. Global women's health pure-play spun out of Merck in 2021, focused on contraception, fertility, and menopause. Directly addresses the same therapeutic categories as Heaton but at much greater scale and global footprint.
- Bayer Consumer Health: Global consumer health giant encompassing OTC, women's health, and intimate care products. Heaton's GYNELLA cosmetics/hygiene range overlaps with Bayer's broad feminine care portfolio, though Bayer operates at vastly larger scale.
- Recordati: Italian specialty pharmaceutical company with strong franchises in urology, gynecology, and rare disease. Comparable in therapeutic focus and geographic mix (European roots expanding globally).
Regional players
- Polpharma: Polish pharmaceutical manufacturer and one of the largest CEE pharma players. Similar mix of Rx and OTC products, comparable CEE-centric distribution model, and overlapping therapeutic areas including women's health and urology.
Direct peers
- KRKA: Slovenian-headquartered generic and specialty pharmaceutical company with broad CEE distribution. Comparable scale and origin to Heaton, with overlapping presence in gynecology, urology, and over-the-counter women's health categories.
- Gedeon Richter: Hungarian-headquartered pharma company with a major women's health franchise (contraception, fertility, menopause). Comparable to Heaton due to CEE origin, prescription + women's health focus, and similar European distribution model.
- Theramex: UK-headquartered specialty pharmaceutical company exclusively focused on women's health (contraception, fertility, menopause, osteoporosis). Closely comparable as a niche women's health player with similar product categories and OTC/Rx split.
- STADA Arzneimittel: German-headquartered pharma company with strong generics, specialty, and consumer health businesses. Comparable in European geographic focus and mix of prescription and OTC consumer products including intimate care.
Emerging players
- Croma-Pharma: Austrian pharmaceutical company specializing in aesthetic medicine, gynecology, and orthopedics with focus on hyaluronic acid-based products. Comparable niche women's health focus and overlapping technology ingredient (hyaluronic acid used in Heaton's GYNELLA AtroGel and Balance).
Market position
Strengths4 records
Weaknesses4 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
Heaton Group social profiles
Digital presenceHeaton Group compliance and trust
Trust signalCompliance7 records
Heaton Group financial estimates
Financial estimateRevenue estimate
Valuation estimate
Heaton Group leadership team
Management profileNumber of profiles
Profiles1 record
Heaton Group subsidiaries and ownership
Company hierarchySubsidiaries5 records
Heaton Group funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Heaton Group M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Heaton Group
What does Heaton Group do?
Heaton Group supplies prescription pharmaceuticals and OTC medical devices across therapeutic areas including gynecology, urology, nephrology, oncology, diabetology, and hospital care. The company holds more than 30 marketing authorizations for prescription medicines and operates the GYNELLA brand of OTC women's health medical devices (Flora, Balance, Silver Caps, Silver Foam, AtroGel, Natal Ferti Gel, Cystilab, intimate hygiene line), along with cosmetics and foods for special medical purposes. Products are sold in 27 countries through owned sales teams, subsidiaries, and a network of international distribution partners.
Is Heaton Group a public or private company?
Heaton Group is a private company. It is classified as family owned and is currently operating.
When was Heaton Group founded?
Heaton Group was founded in 2002. It employs 11 to 50 people.
Where is Heaton Group based?
Heaton Group is headquartered in Prague, Czechia, in the Europe region.
How does Heaton Group make money?
Four revenue lines are on record. Prescription Medicines are the primary driver. The others are medical Devices (OTC), cosmetics and foods for Special Medical Purposes.
Who are Heaton Group's main competitors?
Broad incumbents on record are Perrigo Company, Organon & Co., Bayer Consumer Health and Recordati. Polpharma is listed as a regional player. Direct peers are KRKA, Gedeon Richter, Theramex and STADA Arzneimittel. Croma-Pharma is listed as an emerging player.
Does Heaton Group have an API?
No public API is recorded for Heaton Group.
What industry is Heaton Group in?
Heaton Group's product category is Pharmaceutical Products. Its primary akta.pro industry code is HLAIADAJ, Women’s Health (OTC Gynecologic), with a secondary code of HLAIADAK, Men’s Health (OTC Urologic & Sexual Health). Its NAICS code is 325412 and its SIC code is 2834.